During the past decade, Sentral Clinical Research Services conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 10 clinical trials were completed, i.e. on average, 111.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sentral Clinical Research Services" #1 sponsor was "Allergan" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Urovant Sciences GmbH" with 2 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Esperion Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sentral Clinical Research Services" #1 collaborator was "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Sentral Clinical Research Services" are "Hypercholesterolemia" (2 trials), "Migraine, With or Without Aura" (2 trials), "Overactive Bladder" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Sentral Clinical Research Services" in a lesser frequency.

Most popular intervention types in "Sentral Clinical Research Services" are "Drug" (11 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Placebo-matching Ubrogepant" (2 trials), "Tolterodine Tartrate ER" (2 trials), "Ubrogepant" (2 trials) and "200mg PF-04950615 (RN316)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sentral Clinical Research Services" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Sentral Clinical Research Services". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Sentral Clinical Research Services, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sentral Clinical Research Services, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".